Day: January 19, 2021

METTAWA, Ill., Jan. 19, 2021 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today announced the launch of BoatClass, an immersive on-water training program designed to teach boating safety and assist boaters in gaining confidence on the water.  “Safety is the number one priority for all boaters on the water and BoatClass provides an opportunity for new and seasoned boaters to receive world-class training and learn the necessary skills to make the most of their time on the water,” said Brenna Preisser, Brunswick Corporation President – Business Acceleration & Chief People and Strategy Officer.BoatClass offers boaters two 3-hour course options – basic and intermediate levels – led by a Certified US Coast Guard Captain, which consist of 100 percent on-water training to master techniques such as, shifting and throttle...

GREENWICH, Conn., Jan. 19, 2021 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and logistics solutions, has renewed its contract with frozen food retail leader Iceland Foods for warehousing and distribution services. XPO will implement a phased strategy to increase growth capacity for the British supermarket chain, with scalable initiatives for technology, labor optimization, fleet optimization and cost savings. The renewal extends XPO’s partnership with Iceland to more than a decade.XPO’s distribution solution combines six Iceland warehouses with supplemental capacity at XPO shared-user sites, and additional logistics and transport support as needed for peak demand. XPO manages approximately 3,000 colleagues at Iceland distribution centers in Warrington, Deeside, Enfield, Livingston...

Workers’ Compensation and Other Leave Types, All Managed from a Single Point of IntakeIRVINE, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) — Absence management just got easier due to a new partnership between CorVel, a national provider of risk management solutions, and ReedGroup, a leading provider of absence management. The new partnership offers faster return to work and a better employee experience, within a single integrated program combining workers’ compensation and absence.“Employees who cannot work due to illness or injury are unfamiliar with the process of managing their absence, and the intricacies of workers’ compensation, FMLA, or short-term disability management,” said Diane Blaha, CorVel’s Chief Marketing Officer. “With our new integrated disability program, these employees can now have an easier, more streamlined experience,...

Philadelphia, PA, Jan. 19, 2021 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and retail marketing technology, is partnering with Sky Packets, the New York City-based prominent developer of Wi-Fi Mesh networks and “Smart City” applications for municipalities and business improvement districts, to strategically deploy advanced security and “Smart City” solutions to U.S. and international customers.VSBLTY Co-founder & CEO Jay Hutton, commenting on the strategic deal, said, “We are particularly excited to partner with Sky Packets because there is a growing need worldwide for intelligent integrated security and ‘Smart City’ applications for municipal governments, business districts, transit operators, among others.” He explained that the joint...

PETAH TIKVA, Israel, Jan. 19, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announces that AXESS awards Gilat multi-million dollars for cellular backhaul (CBH) projects in Mexico, to power network expansion for two of the key Mobile Network Operators (MNOs) in Mexico. Gilat’s cellular backhaul solution over satellite enables connectivity for hundreds of sites, in the first phase, to support bridging the digital divide throughout Mexico.Gilat’s multi-application, scalable SkyEdge II-c platform is being leveraged by AXESS to broaden and expand its service. In addition to CBH projects, AXESS has been providing service to an assortment of industries including: Oil & Gas, Retail, Mining as well as for Corporate...

前立腺がんおよび膵がん患者にリムパーザによる治療を利用可能に日本の2万人を超える患者が遺伝子検査対象にソルトレークシティ, Jan. 19, 2021 (GLOBE NEWSWIRE) — 遺伝子検査とプレシジョン･メディシンのリーダーであるミリアド･ジェネティクス (Myriad Genetics, Inc.) (NASDAQ: MYGN) は、BRACAnalysis®診断システムの日本での保険適用を取得したことを発表した。これにより医師は、進行前立腺がんおよび膵がん患者の一部にPARP阻害剤のリムパーザ (オラパリブ) による治療を適応して有効性が得られる可能性を判断しやすくなる。BRACAnalysisは、2020年10月に厚生労働省 (MHLW) からこれらの症状のコンパニオン診断薬として承認され、今回保険適用が発効した。ミリアド･ジェネティクス･ラボラトリーズ (Myriad Genetic Laboratories) 社長のニコル･ランベール (Nicole Lambert) は次のように述べている。「BRACAnalysisは、生殖細胞系列BRCA1およびBRCA2検査の世界的標準となっています。当社の目標は、実証済みの遺伝子検査のメリットの利用可能性を患者に継続的に拡張し、最も治療が困難ながんとも医師が闘えるよう支援することです。」ミリアドの推定によると、日本での患者数は年間に前立腺がん78,000件以上、膵がん40,000件以上にのぼる。保険適用が決まったことにより、日本で約2万人の患者に遺伝子検査を適用できるようになる。BRACAnalysisは、生殖細胞系列BRCAの変異が陽性の卵巣がんおよび乳がん患者の特定で、日本ですでに承認を受けており、リムパーザによる治療対象となっている。BRACAnalysisは、日本で唯一規制承認を受けている生殖細胞系列BRCA1およびBRCA2の変異検査法である。横浜市立大学医学部泌尿器･腎移植科の上村博司教授は次のように述べている。「日本でもBRCA1やBRCA2の病的変異やその疑いがある症例にBRACAnalysisを利用できるようになったため、より多くの前立腺がんおよび膵がん患者が先進治療を受けられるようになります。」国立がん研究センター中央病院肝胆膵内科の上野秀樹医長は次のように述べている。「医師として、BRACAnalysisを使用して先進治療を必要とする患者を特定し、これらのがんと闘病する患者の健康転帰を継続的に改善できることを大変嬉しく思っています。」ミリアドは、2007年からアストラゼネカ...

Patients with Prostate or Pancreatic Cancer to Benefit from Treatment with LynparzaMore Than 20,000 Patients in Japan Now Qualify for Genetic TestingSALT LAKE CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) — In an announcement that will help more people with advanced prostate and pancreatic cancers in Japan, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will receive reimbursement for its BRACAnalysis® Diagnostic System, which helps physicians determine whether certain patients will qualify and potentially benefit from treatment with the PARP inhibitor, Lynparza (olaparib). BRACAnalysis was approved by Japan’s Ministry of Health, Labour and Welfare (MHLW) in October 2020 as a companion diagnostic for these indications and the reimbursement decision is now in effect.“BRACAnalysis continues to be the...

The Company’s Stock Will Continue to be Listed and Traded on The Nasdaq Stock MarketNEWTOWN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that it received written notice from The Nasdaq Stock Market LLC that the Company’s minimum bid price deficiency has been cured, and that the Company is in compliance with all applicable listing standards. Accordingly, the scheduled hearing before the Hearings Panel to appeal the previous determination of non-compliance has been cancelled, and shares of the Company’s Class A common stock will continue to be listed and trade on The Nasdaq Capital Market under the ticker “HSDT.”About Helius Medical Technologies, Inc.Helius Medical Technologies is a...

VANCOUVER, British Columbia, Jan. 19, 2021 (GLOBE NEWSWIRE) — Newcore Gold Ltd. (“Newcore” or the “Company”) (TSX-V: NCAU; OTCQX: NCAUF) is pleased to announce that the Company’s shares commenced trading today on the OTCQX® Best Market in the United States under the symbol “NCAUF”.Luke Alexander, President & CEO of Newcore stated, “We are extremely pleased to begin trading on the OTCQX. This is an important step to strengthen accessibility to U.S. investors, while continuing to improve our liquidity and global visibility to the benefit of all investors. We have substantially increased our shareholder base in the last several months as we aggressively advance drilling and exploration of our Enchi Gold Project in Ghana, and we believe this additional milestone is an important step in...

● Synopsis of 2020 Achievements and Key Activities for 2021 ●CALGARY, Alberta, Jan. 19, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to provide a synopsis of 2020 achievements and guidance on key activities for 2021.2020 represented a pivotal year for XORTX and a year that provided several key milestones for the Company. The advent of the COVID crisis in March produced a worldwide impact on individuals and across a wide variety of industries. Presented with this new challenge XORTX undertook an internal strategic assessment of programs. Simultaneously, our robust knowledge of the uric acid lowering agent class of drugs and more specifically xanthine...